A fast-track to end the AIDS epidemic

Home to the third-largest number of people living with HIV in Asia and the Pacific, Indonesia is a country critical to ending the AIDS epidemic in the region and on this World AIDS Day we are at a defining moment.

Only three decades since HIV arrived in this country, we can begin to close the chapter on one of modern history’s worst epidemics. In September, Indonesia was one of 193 United Nations member states to adopt the Sustainable Development Goals and commit to ending the AIDS epidemic as a public health threat by 2030.

This goal is certainly ambitious but it is achievable. Even without a vaccine or a cure, we know how to stop HIV. Indonesia can pride itself on being a pathfinder in the AIDS epidemic on the global stage.

In 2013 the Indonesian government launched the Strategic Use of AIDS (SUFA) policy – a pioneering strategy that made antiretroviral treatment available immediately for any person diagnozed with HIV. Providing early treatment has the double advantage of keeping people living with HIV healthy and stopping further transmission of the virus. Last month, the World Health Organization endorsed a similar policy for all countries.

The program has now been rolled out in 75 districts. The number of ART sites has more than doubled since 2008 and more than 50 000 people were accessing HIV treatment in 2014, compared with less than 2 500 in 2005. The program is a good indication of how the Indonesian government has sought new and innovative approaches in responding to HIV, and is one of the first in Asia to use treatment as prevention in reducing HIV transmission.

At the end of 2014, just a year and a half after the SUFA program was launched, HIV testing has reached slightly more than 1 million people, which is more than five times the number tested in 2010. There has been a massive expansion of prevention services, including condom distribution in key locations and harm reduction programs for people who inject drugs.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below